Growth follow up of SGA children after 3 years of GH treatment;Suivi de la croissance chez les enfants de petite taille de naissance après 3 ans de traitement par hormone de croissance : l'expérience d'un centre français

Archives de Pediatrie

Volumn 15, Issue 2, 2008, Pages 115-121

  Edouard, T ^a,b   Oliver, I ^a   Jouret, B ^a   Lounis, N ^a   Moulin, P ^a   Pienkowski, C ^a   Elefterion, M ^a   Salles, J P ^a,b   Tauber, M ^a,b  

^a HÔPITAL DES ENFANTS   (France)

^b University of Toulouse III   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FETUS GROWTH; FOLLOW UP; GROWTH RATE; HORMONAL THERAPY; HUMAN; SMALL FOR DATE INFANT; TREATMENT DURATION; TREATMENT WITHDRAWAL;

AGE FACTORS; BODY HEIGHT; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MALE; SEX FACTORS; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 39149139322     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2007.10.021     Document Type: Article

References (23)

1. Karlberg J., and Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants : from birth to final height. Pediatr Res 38 (1995) 733-739
2. Carel J.C., Chatelain P., Rochiccioli P., et al. Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestationnal age: results of a randomized controlled study. J Clin Endocrinol Metab 88 (2003) 1587-1593
3. Van Pareren Y., Mulder P., Houdijk M., et al. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestationnal age: results of a randomized, double-blind, dose-response GH trial. J Clin Endocrinol Metab 88 (2003) 3584-3590
4. Fiche d'information thérapeutique, médicament d'exception Maxomat. Journal Officiel de la République Française 29 janvier 1997.
5. Fiche d'information thérapeutique, médicament d'exception. Journal Officiel de la République Française 16 mars 2003.
6. Usher R., and Mac Lean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 74 (1969) 901-910
7. Sempé M., Pedron G., and Roy-Pernot M.P. Auxologie, méthodes et séquences. Théraplix (1979)
8. Rolland-Cachera M.F., Cole T.J., Sempé M., et al. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 45 (1991) 13-21
9. Tanner J.M. Growth and adolescence (1969), Blackwell, Oxford
10. nd Edn. (1959), University Press, Stanford
11. Albertsson-Wikland K., Boguszenski M., and Karlberg J. Children born small-for-gestational age: postnatal growth and hormonal status. Horm Res 49 suppl 2 (1998) 7-13
12. Leger J., Levy-Marchal C., Bloch J., et al. Reduced final height and indications for insulin resistance in 20 year olds born small for gestationnal age: regional cohort study. BMJ 315 (1997) 341-347
13. Luo Z., Albertsson-Wikland K., and Karlberg J. Lenght and body mass index at birth and target height influences on patterns of postnatal growth in children born small for gestational age. Pediatrics 102 (1998) E72
14. Job J.C., Chaussain J.L., Job B., et al. Follow-up of three years of treatment with growth hormone and one post-treatment year, in children with severe growth retardation of intrauterine onset. Pediatr Res 39 (1996) 354-359
15. Chaussain J.L., Colle M., and Landier F. Effects of growth hormone therapy in prepubertal children with short stature secondary to intrauterine growth retardation. Acta Paediatr Suppl 399 (1994) 74-75
16. Coutant R., Carel J.C., Letrait M., et al. Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children. J Clin Endocrinol Metab 83 (1998) 1070-1074
17. Rosilio M., Carel J.C., Blazy D., et al. Growth hormone treatment of children with short stature secondary to intra-uterine growth retardation: effect of 2 years'treament and 2 years'follow-up. Horm Res 48 suppl 4 (1997) 23-28
18. Czernichow P., and Fjellestad-Paulsen A. Growth hormone in the treatment of short stature in young children with intrauterine growth retardation. Horm Res 49 suppl 2 (1998) 23-27
19. Fjellestad-Paulsen A., Simon D., and Czernichow P. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment. J Clin Endocrinol Metab 89 (2004) 1234-1239
20. Ibrahim Yh, and Yee D. Insulin-like growth factor-I and cancer risk. Growth Horm IGF Res 14 (2004) 261-269
21. Barker D.J., Hales C.N., Fall C.H., et al. Type 2 (non-insulin dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologica 36 (1993) 62-67
22. Cutfielf W.S., Wilton P., Bennmarker H., et al. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet 355 (2000) 610-613
23. De Zegher F., Ong K., Van Helvoirt M., et al. High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestationnal age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity. J Clin Endocrinol Metab 87 (2002) 148-151